Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma
Ontology highlight
ABSTRACT: Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma
PROVIDER: PRJNA449722 | ENA |
REPOSITORIES: ENA
ACCESS DATA